Abstract
Crimean-Congo hemorrhagic fever (CCHF) is an acute tick-borne zoonotic disease. The disease has been reported in many countries of Africa, Asia, the Middle East, and in Eurasia. During the past decade, new foci of CCHF have emerged in the Balkan Peninsula, southwest Russia, the Middle East, western China, India, Africa, and Turkey. CCHF virus produces severe hemorrhagic manifestations in humans with fatality rates up to 30%. Vaccine development efforts have been significantly hampered by a lack of animal models and therefore, no protective vaccine has been achieved. Lately, IFN α/β receptor deficient (IFNAR-/-) mice have been established as a novel small animal model of CCHF virus infection. In the present study, we found that IFNAR-/- mice highly susceptible to CCHF virus Turkey-Kelkit06 strain. Immunization with the cell culture based vaccine elicited a significant level of protection against high dose challenge (1,000 PPFU) with a homologous CCHF virus in IFNAR-/- mice.
References
May 22, 1979·Journal of Medical Entomology·H Hoogstraal
Nov 20, 2004·Antiviral Research·Chris A Whitehouse
Apr 29, 2005·Journal of Virology·Andrea Bertolotti-CiarletRobert W Doms
Sep 22, 2005·Vaccine·Kristin SpikConnie SchmalJohn
Mar 24, 2006·The Lancet Infectious Diseases·Onder Ergönül
May 17, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·O ErgonulB Dokuzoguz
Oct 24, 2007·Archives of Virology·A OzdarendeliA Kalkan
Jan 26, 2008·Emerging Infectious Diseases·Darja DuhTatjana Avsic-Zupanc
Apr 10, 2009·PloS One·Eva Calvo-PinillaJavier Ortego
Nov 28, 2009·Virus Research·Aykut OzdarendeliAhmet Kalkan
Dec 17, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·S ChinikarA Haeri
Feb 19, 2010·The Journal of General Virology·Sándor BereczkyAli Mirazimi
May 21, 2010·Clinical and Vaccine Immunology : CVI·Ana SaksidaTatjana Avsic-Zupanc
Aug 27, 2010·Journal of Virology·Dennis A BenteSteven M Jones
Dec 15, 2010·Scandinavian Journal of Infectious Diseases·Anna PapaIva Christova
Mar 3, 2011·Antiviral Research·Maryam Keshtkar-JahromiSina Bavari
Oct 21, 2011·Clinical and Vaccine Immunology : CVI·S M GhiasiS Zakeri
Apr 4, 2012·Emerging Infectious Diseases·Hürrem BodurYavuz Uyar
Aug 21, 2012·Vaccine·Mehrdad Mousavi-JaziAli Mirazimi
Aug 22, 2012·Journal of Virological Methods·Engin BerberAykut Ozdarendeli
Jan 4, 2013·Virology Journal·Nurettin CanakogluAykut Ozdarendeli
Feb 19, 2013·The Journal of Infectious Diseases·Marko ZivcecHeinz Feldmann
Jul 23, 2013·PLoS Neglected Tropical Diseases·Elena López-GilAlejandro Brun
Aug 3, 2013·Antiviral Research·Dennis A BenteMike Bray
Mar 14, 2014·PloS One·Karen R ButtigiegMiles W Carroll
Citations
Apr 26, 2016·Viruses·Marko ZivcecÉric Bergeron
Mar 20, 2016·Vaccine·Miguel A Martín-AcebesJuan-Carlos Saiz
May 2, 2018·Japanese Journal of Infectious Diseases·Yuto SudaMasayuki Shimojima
Jul 17, 2018·PLoS Neglected Tropical Diseases·Marko ZivcecHeinz Feldmann
Mar 3, 2017·Journal of Virology·Jorma HinkulaAli Mirazimi
Sep 19, 2017·PLoS Neglected Tropical Diseases·Aura R GarrisonConnie S Schmaljohn
Nov 13, 2018·F1000Research·David W Hawman, Heinz Feldmann
Jul 3, 2019·Viruses·Aura R GarrisonJoseph W Golden
Mar 23, 2019·BMJ Global Health·Laura T Mazzola, Cassandra Kelly-Cirino
Aug 14, 2020·PLoS Neglected Tropical Diseases·Robert W CrossThomas W Geisbert
May 28, 2019·Scientific Reports·Sergio E RodriguezThomas W Geisbert
May 29, 2020·BioResearch Open Access·Thomas Tipih, Felicity Jane Burt
Jun 9, 2016·PloS One·Stuart D DowallRoger Hewson
Jan 11, 2019·Viruses·Alejandro Marín-LopezJavier Ortego
Mar 20, 2020·Archives of Virology·Abbas Ahmadi VasmehjaniShohreh Shahmahmoodi
Nov 24, 2020·PLoS Neglected Tropical Diseases·Shaikh Terkis Islam PavelAykut Ozdarendeli
Dec 2, 2020·Nature Microbiology·David W HawmanAli Mirazimi
Sep 20, 2020·Antiviral Research·Koray ErgünayAykut Özkul
Mar 4, 2021·NPJ Vaccines·John J SuschakAura R Garrison